Biovac TCV Typhoid Vi Conjugate Vaccine IP
Biovac TCV Typhoid Vi Conjugate Vaccine IP by Dr. Reddy's is an injectable vaccine used for the active immunization against typhoid fever. It contains purified Vi polysaccharide of Salmonella typhi, conjugated to a carrier protein, offering enhanced protection and longer immunity duration, particularly suitable for children above 6 months and adults.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Conjugate vaccine: Offers longer-lasting immunity than polysaccharide vaccines
-
Safe for use in children as young as 6 months
-
Single-dose protection with potential long-term immunity
-
Clinically tested for safety and efficacy
-
Ready-to-use prefilled syringe for ease of administration
| Technical Specification |
|
|---|
- 0.5 ml single-dose prefilled syringe (PFS)
-
Provides longer-lasting immunity than traditional typhoid vaccines
-
Can be administered to infants, children, and adults
-
Reduces the carrier state and transmission risk
-
Requires only a single dose for effective protection
-
Easy-to-administer prefilled syringe format
